These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3197580)

  • 21. Dual effects of cisapride on gastric emptying and antropyloroduodenal motility.
    Fraser R; Horowitz M; Maddox A; Dent J
    Am J Physiol; 1993 Feb; 264(2 Pt 1):G195-201. PubMed ID: 8447401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.
    Camilleri M; Malagelada JR; Abell TL; Brown ML; Hench V; Zinsmeister AR
    Gastroenterology; 1989 Mar; 96(3):704-12. PubMed ID: 2644150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients.
    Testoni PA; Bagnolo F; Fanti L; Passaretti S; Tittobello A
    Gut; 1990 Mar; 31(3):286-90. PubMed ID: 2323591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cisapride on myoelectrical and motor responses of antropyloroduodenal region during intraduodenal lipid and antral tachygastria in conscious dog.
    Edelbroek M; Schuurkes J; De Ridder W; Horowitz M; Dent J; Akkermans L
    Dig Dis Sci; 1995 Apr; 40(4):901-11. PubMed ID: 7720488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small bowel motility following major intra-abdominal surgery: the effects of opiates and rectal cisapride.
    Benson MJ; Roberts JP; Wingate DL; Rogers J; Deeks JJ; Castillo FD; Williams NS
    Gastroenterology; 1994 Apr; 106(4):924-36. PubMed ID: 8143997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between jejunal myoelectric activity after a meal and during phase 2 of migrating motor complexes in healthy humans.
    Staumont G; Delvaux M; Fioramonti J; Berry P; Bueno L; Frexinos J
    Dig Dis Sci; 1992 Oct; 37(10):1554-61. PubMed ID: 1396003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisapride prevents enteric bacterial overgrowth and translocation by improvement of intestinal motility in rats with acute liver failure.
    Wang XD; Soltesz V; Andersson R
    Eur Surg Res; 1996; 28(6):402-12. PubMed ID: 8954316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of a new gastrointestinal prokinetic; pharmacology of cisapride].
    Van Nueten JM; Schuurkes JA
    J Pharm Belg; 1991; 46(1):17-22. PubMed ID: 2051298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors.
    Taniyama K; Nakayama S; Takeda K; Matsuyama S; Shirakawa J; Sano I; Tanaka C
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1098-104. PubMed ID: 1890614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisapride stimulates human esophageal motility.
    Katschinski M; Wank U; Ducree M; Schirra J; Arnold R
    Digestion; 1995; 56(2):153-8. PubMed ID: 7750669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small bowel motility affects glucose absorption in a healthy man.
    Schwartz MP; Samsom M; Renooij W; van Steenderen LW; Benninga MA; van Geenen EJ; van Herwaarden MA; de Smet MB; Smout AJ
    Diabetes Care; 2002 Oct; 25(10):1857-61. PubMed ID: 12351491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisapride improves nicotine-evoked antral hypomotility in smokers.
    Ohnishi H
    Kurume Med J; 1997; 44(4):253-62. PubMed ID: 9476468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cisapride on distal colonic motility in the early postoperative period following left colonic anastomosis.
    Roberts JP; Benson MJ; Rogers J; Deeks JJ; Wingate DL; Williams NS
    Dis Colon Rectum; 1995 Feb; 38(2):139-45. PubMed ID: 7851167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cisapride. A new agent which stimulates gastrointestinal motility].
    Husebye E
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):981-2. PubMed ID: 2321233
    [No Abstract]   [Full Text] [Related]  

  • 36. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
    Rezende-Filho J; Di Lorenzo C; Dooley CP; Valenzuela JE
    Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interdigestive migrating complex (IMC) and effect of cisapride in patients with non-ulcer dyspepsia (NUD)].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M; Matsuzaki T; Kawamura O; Miyazaki M; Kikuchi K
    J Smooth Muscle Res; 1991 Jun; 27(3):131-7. PubMed ID: 1840866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory small intestinal manometry. Detailed comparison of duodenal and jejunal motor activity in healthy man.
    Wilmer A; Andrioli A; Coremans G; Tack J; Janssens J
    Dig Dis Sci; 1997 Aug; 42(8):1618-27. PubMed ID: 9286226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentagastrin induced motility pattern in the human upper gastrointestinal tract is reversed by proglumide.
    Erckenbrecht JF; Caspari J; Wienbeck M
    Gut; 1984 Sep; 25(9):953-6. PubMed ID: 6469080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prokinetic effects of cisapride, naloxone and parasympathetic stimulation at the equine ileo-caeco-colonic junction.
    Ruckebusch Y; Roger T
    J Vet Pharmacol Ther; 1988 Dec; 11(4):322-9. PubMed ID: 3210259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.